Growth Metrics

LifeMD (LFMD) Common Equity (2016 - 2025)

Historic Common Equity for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $3.4 million.

  • LifeMD's Common Equity rose 16607.66% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 16607.66%. This contributed to the annual value of -$9.1 million for FY2024, which is 31683.24% down from last year.
  • According to the latest figures from Q3 2025, LifeMD's Common Equity is $3.4 million, which was up 16607.66% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Common Equity registered a high of $22.7 million during Q4 2021, and its lowest value of -$18.7 million during Q3 2021.
  • For the 5-year period, LifeMD's Common Equity averaged around -$3.0 million, with its median value being -$2.3 million (2025).
  • Per our database at Business Quant, LifeMD's Common Equity skyrocketed by 154184.31% in 2022 and then crashed by 82612.2% in 2023.
  • LifeMD's Common Equity (Quarter) stood at $22.7 million in 2021, then tumbled by 152.2% to -$11.9 million in 2022, then soared by 135.29% to $4.2 million in 2023, then crashed by 316.83% to -$9.1 million in 2024, then skyrocketed by 137.08% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, -$1.8 million for Q2 2025, and -$2.3 million during Q1 2025.